Product Code: ETC7544343 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Geographic Atrophy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Geographic Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 India Geographic Atrophy Market - Industry Life Cycle |
3.4 India Geographic Atrophy Market - Porter's Five Forces |
3.5 India Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 India Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 India Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
4 India Geographic Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in India |
4.2.2 Rising geriatric population leading to higher incidence of geographic atrophy |
4.2.3 Technological advancements in diagnostic tools and treatment options |
4.3 Market Restraints |
4.3.1 Lack of awareness about geographic atrophy and its symptoms among the general population |
4.3.2 High cost associated with diagnostic tests and treatment for geographic atrophy |
4.3.3 Limited access to specialized healthcare facilities in remote areas of India |
5 India Geographic Atrophy Market Trends |
6 India Geographic Atrophy Market, By Types |
6.1 India Geographic Atrophy Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 India Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F |
6.1.3 India Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.1.4 India Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2 India Geographic Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 India Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F |
6.2.3 India Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F |
6.2.4 India Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F |
6.3 India Geographic Atrophy Market, By Therapeutic Agents Clinical Phase |
6.3.1 Overview and Analysis |
6.3.2 India Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F |
6.3.3 India Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 India Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F |
7 India Geographic Atrophy Market Import-Export Trade Statistics |
7.1 India Geographic Atrophy Market Export to Major Countries |
7.2 India Geographic Atrophy Market Imports from Major Countries |
8 India Geographic Atrophy Market Key Performance Indicators |
8.1 Number of patients diagnosed with geographic atrophy annually |
8.2 Adoption rate of advanced diagnostic tools for early detection of geographic atrophy |
8.3 Rate of reimbursement for geographic atrophy treatments by health insurance providers |
8.4 Number of healthcare facilities offering specialized care for geographic atrophy |
9 India Geographic Atrophy Market - Opportunity Assessment |
9.1 India Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 India Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 India Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
10 India Geographic Atrophy Market - Competitive Landscape |
10.1 India Geographic Atrophy Market Revenue Share, By Companies, 2024 |
10.2 India Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |